Top Markets
#1 Black Phoenix Black Phoenix +830.60%
#2 YFSX YFSX +35.49%
#3 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +26.20%
#4 Not in Employment, Education, or Training Not in Employment, Education, or Training +25.44%
#5 Beam Beam +22.54%
#6 SAFEcoin SAFEcoin +20.74%
#7 pipedog pipedog +18.64%
#8 Magma Finance Magma Finance +17.22%
#9 THORChain THORChain +15.82%
#10 Nosana Nosana +15.79%
Coin of the day
Black Phoenix Black Phoenix
Configuración
Idioma
ESPAñOL
Moneda
USD
Tema
Kailera Therapeutics, Inc. Kailera Therapeutics, Inc.

Kailera Therapeutics, Inc.

KLRA
Clasificación en acciones #5958
Kailera Therapeutics is a biopharmaceutical company currently advancing through... Kailera Therapeutics is a biopharmaceutical company currently advancing through its clinical development stage, dedicated to cultivating a varied portfolio of cutting-edge treatments. These therapeutics are specifically engineered to tackle obesity and its associated metabolic disorders. The company distinguishes itself through its focus on innovative methodologies, offering both injectable and orally administered formulations for sustainable weight management. Its most advanced candidate is a groundbreaking dual-action gut hormone receptor agonist, which has reported encouraging outcomes in its initial clinical investigations.
Precio por acción
$18.55
Capitalización bursátil
$2.40B
Cambio (1 día)
0.60%
Cambio (1 año)
-
País
US
Comercio Kailera Therapeutics, Inc. (KLRA)

Categoría

Healthcare
Historial de rendimiento por dividendo de Kailera Therapeutics, Inc. (KLRA)
Rendimiento por dividendo (TTM) de Kailera Therapeutics, Inc. (símbolo bursátil: KLRA) al 2026: 0
Rendimiento promedio por dividendo de los últimos 5 años: 0.00%
Historial de rendimiento por dividendo de Kailera Therapeutics, Inc. (KLRA) desde 2026 hasta 2026
Rendimiento por dividendo al final de cada año (TTM)
Año Rendimiento por dividendo Cambiar
Not enough data for the provided dates.
Rendimientos por dividendo (TTM) de empresas similares o competidoras
Empresa Rendimiento por dividendo País
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
0.00%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
0.00%
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
3.12%
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
0.00%
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
0.00%
CH